These U.S. and Canadian companies are scheduled to report their quarterly earnings today. Below is a preview of their key earning metrics, based on consensus estimates of analysts polled by Bloomberg. We have also provided analysts’ consensus buy ratings for these stocks with upside/downside potential for the upcoming 12-months.
| Company | Ticker | Exchange | Market Cap (MM) |
Last Price | Industry | Reporting Time |
Quarter | Sales ($MM) (Growth) |
Net Income ($MM) (Growth) |
EPS ($) (Growth) |
Total Analyst Coverage |
Buy Ratings | Upside Potential |
| ITT Corp | ITT | NYSE | 3,749.5 | 41.34 | Diversified Manufact Op | 07:00 | 4Q 2013 | 632.40 (14.1%) |
42.60 (92.8%) |
0.48 (97.9%) |
10 | 50% | 14.5% |
| IPG Photonics Corp | IPGP | NASDAQ | 3,507.0 | 67.86 | Telecom Eq Fiber Optics | NA | 4Q 2013 | 163.90 (13.0%) |
38.90 (11.4%) |
0.75 (11.6%) |
12 | 67% | 21.9% |
| LifePoint Hospitals Inc | LPNT | NASDAQ | 2,515.4 | 53.50 | Medical-Hospitals | BMO | 4Q 2013 | 941.78 (5.4%) |
37.78 (3.5%) |
0.80 (5.1%) |
25 | 36% | 9.2% |
| Tredegar Corp | TG | NYSE | 783.5 | 24.27 | Diversified Manufact Op | NA | 4Q 2013 | 231.00 (-5.0%) |
8.70 (-37.2%) |
0.27 (-37.2%) |
2 | 0% | NA |
| PTC Therapeutics Inc | PTCT | NASDAQ | 759.4 | 26.03 | Medical-Biomedical/Gene | NA | 4Q 2013 | 6.05 (NA) |
-13.95 (NA) |
-0.58 (NA) |
4 | 75% | 69.0% |
| Chimerix Inc | CMRX | NASDAQ | 516.3 | 19.54 | Medical-Drugs | NA | 4Q 2013 | 1.21 (NA) |
-11.00 (NA) |
-0.36 (NA) |
6 | 83% | 57.4% |
| Tetraphase Pharmaceuticals Inc | TTPH | NASDAQ | 354.0 | 14.06 | Medical-Drugs | NA | 4Q 2013 | 2.10 (NA) |
-9.70 (NA) |
-0.46 (NA) |
9 | 89% | 21.9% |
| Arbor Realty Trust Inc | ABR | NYSE | 346.4 | 7.05 | REITS-Mortgage | BMO | 4Q 2013 | NA | 2.70 (NM) |
0.06 (NM) |
3 | 100% | NA |
| New Source Energy Partners LP | NSLP | NYSE | 269.9 | 24.01 | Oil&Gas Drilling | NA | 4Q 2013 | 12.90 (NA) |
2.05 (NA) |
0.25 (NA) |
6 | 100% | 4.1% |
| Five Star Quality Care Inc | FVE | NYSE | 261.6 | 5.42 | Retirement/Aged Care | NA | 4Q 2013 | 343.00 (3%) |
2.19 (-36%) |
0.04 (-38%) |
6 | 50% | 29.2% |
| Conatus Pharmaceuticals Inc | CNAT | NASDAQ | 184.2 | 11.79 | Medical-Drugs | NA | 4Q 2013 | NA | -3.98 (NA) |
-0.25 (NA) |
4 | 100% | 33.6% |
| IsoRay Inc | ISR | NYSE | 27.7 | 0.72 | Medical Products | NA | 2Q 2014 | 1.12 (15%) |
NA | -0.03 (0%) |
1 | 100% | 108.3% |
| TAG Oil Ltd | TAO | TSX | 193.2 | 3.00 | Oil Comp-Explor&Prodtn | NA | 3Q 2014 | 12.70 (32%) |
NA | 0.08 (NM) |
7 | 57% | 110.3% |
| Labrador Iron Mines Holdings Ltd | LIM | TSX | 29.0 | 0.23 | Metal-Iron | NA | 3Q 2014 | 37.73 (53%) |
-20.30 (-26%) |
-0.13 (32%) |
9 | 11% | 68.5% |
| Niko Resources Ltd | NKO | TSX | 269.3 | 3.02 | Oil Comp-Explor&Prodtn | NA | 3Q 2014 | 33.00 (-29%) |
-23.40 (75%) |
-0.45 (72%) |
10 | 20% | 21.4% |
Source: Bloomberg
Note: Sales, Net Income & EPS are Bloomberg estimated figures and the growth rates mentioned are year-over-year.
AMC: After Market Close
BMO: Before Market Open
NA: Not Available
NM: Not Meaningful
